A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. [electronic resource]
Producer: 20100305Description: 230-6 p. digitalISSN:- 1941-7632
- Abciximab
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Eptifibatide
- Female
- Hemorrhage -- chemically induced
- Humans
- Immunoglobulin Fab Fragments -- adverse effects
- Male
- Middle Aged
- Myocardial Infarction -- mortality
- Odds Ratio
- Peptides -- adverse effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Recurrence
- Risk Assessment
- Risk Factors
- Thrombosis -- etiology
- Time Factors
- Tirofiban
- Treatment Outcome
- Tyrosine -- adverse effects
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.